Aerobic Exercise Performance and Muscle Strength in Statin Users

Purpose of the study?

Determine whether statin-associated myalgia impairs aerobic exercise performance, fat oxidation, or muscle strength.

Why was this study conducted?

Statins can cause muscle pain (myalgia), which may reduce muscle function and physical activity.

What was the primary research question?

Do statin users with myalgia have worse aerobic fitness or muscle strength than statin users without myalgia or non-users?

Main conclusion?

Statin users with myalgia did not have impaired aerobic exercise performance or muscle strength compared with statin users without myalgia or controls.

What did the study find about aerobic capacity?

No significant differences between statin users with myalgia, statin users without myalgia, and controls.

What did the study find about fat oxidation?

Maximal fat oxidation was similar across all groups.

What did the study find about muscle strength?

Muscle strength, rate of force development, and leg power were not significantly different between groups.

What percentage of statin users reported myalgia?

Approximately 19%.

Clinical implication?

Patients with statin-associated muscle pain can generally continue aerobic and resistance exercise because performance and strength are not significantly impaired.

PT implication?

Do not assume muscle pain from statins means reduced exercise capacity; objectively assess function before limiting activity.

Key take-home message?

Statin-associated myalgia does not necessarily translate to measurable deficits in aerobic fitness or muscle strength.

How should PTs apply these findings?

Encourage appropriate exercise participation while monitoring symptoms rather than restricting activity solely because of statin-associated myalgia.